Sol Gel Technologies Ltd
SLGL33.500USD
-2.000-5.63%
收盤 11/04, 16:00（美東）報價延遲15分鐘
93.32M總市值
虧損本益比TTM
關於 Sol Gel Technologies Ltd 公司
Sol-Gel Technologies Ltd 是一家臨牀階段的皮膚病學公司。該公司專注於識別、開發和商業化用於治療皮膚病的品牌和仿製外用藥物產品。該公司提供一系列產品，包括 twins、sirs-t 和 vered。該公司設計了其專有的基於二氧化硅的微膠囊技術平臺，以提高外用藥物的耐受性和穩定性，同時保持其功效。外用藥物通常難以在實現高功效和高耐受性之間取得平衡。其技術平臺將活性成分包裹在惰性無機二氧化硅殼中，從而在活性成分和皮膚之間形成一道不明顯的屏障。
Sol Gel Technologies Ltd簡介
公司代碼SLGL
公司名稱Sol Gel Technologies Ltd
上市日期Feb 01, 2018
CEO- -
員工數量34
證券類型Ordinary Share
年結日Feb 01
公司地址Golda Meir 7
城市NESS-ZIONA
上市交易所NASDAQ Capital Market Consolidated
國家Israel
郵編- -
電話97289313433
網址http://www.sol-gel.com
公司代碼SLGL
上市日期Feb 01, 2018
CEO- -
Sol Gel Technologies Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Moshe (Mori) Arkin
Mr. Moshe (Mori) Arkin
Executive Chairman of the Board
Executive Chairman of the Board
143.26K
+275.67%
Dr. Karine Neimann, Ph.D.
Dr. Karine Neimann, Ph.D.
Vice President - Projects and Planning, Chief Chemist
Vice President - Projects and Planning, Chief Chemist
--
--
Ms. Yaffa Krindel
Ms. Yaffa Krindel
Independent Director
Independent Director
--
--
Dr. Shmuel (Muli) Ben Zvi, Ph.D.
Dr. Shmuel (Muli) Ben Zvi, Ph.D.
Independent Director
Independent Director
--
--
Mr. Ran Gottfried
Mr. Ran Gottfried
Lead Independent Director
Lead Independent Director
--
--
Mr. Eyal Ben-Or
Mr. Eyal Ben-Or
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Hani Lerman
Ms. Hani Lerman
Director
Director
--
--
Dr. Ofra Levy-Hacham, Ph.D.
Dr. Ofra Levy-Hacham, Ph.D.
Vice President - Clinical and Regulatory Affairs
Vice President - Clinical and Regulatory Affairs
--
--
Dr. Ofer Toledano, Ph.D.
Dr. Ofer Toledano, Ph.D.
Vice President - Research and Development
Vice President - Research and Development
--
--
Mr. Nissim Bilman
Mr. Nissim Bilman
Vice President - Quality
Vice President - Quality
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Moshe (Mori) Arkin
Mr. Moshe (Mori) Arkin
Executive Chairman of the Board
Executive Chairman of the Board
143.26K
+275.67%
Dr. Karine Neimann, Ph.D.
Dr. Karine Neimann, Ph.D.
Vice President - Projects and Planning, Chief Chemist
Vice President - Projects and Planning, Chief Chemist
--
--
Ms. Yaffa Krindel
Ms. Yaffa Krindel
Independent Director
Independent Director
--
--
Dr. Shmuel (Muli) Ben Zvi, Ph.D.
Dr. Shmuel (Muli) Ben Zvi, Ph.D.
Independent Director
Independent Director
--
--
Mr. Ran Gottfried
Mr. Ran Gottfried
Lead Independent Director
Lead Independent Director
--
--
Mr. Eyal Ben-Or
Mr. Eyal Ben-Or
Chief Financial Officer
Chief Financial Officer
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 11月4日 週二
更新時間: 11月4日 週二
持股股東
股東類型
持股股東
持股股東
佔比
M.Arkin Dermatology, Ltd.
64.86%
Arkin (Moshe)
5.14%
Opaleye Management Inc.
5.00%
Migdal Insurance and Financial Holdings Ltd
4.41%
Raymond James Financial Services Advisors, Inc.
0.28%
其他
20.31%
持股股東
持股股東
佔比
M.Arkin Dermatology, Ltd.
64.86%
Arkin (Moshe)
5.14%
Opaleye Management Inc.
5.00%
Migdal Insurance and Financial Holdings Ltd
4.41%
Raymond James Financial Services Advisors, Inc.
0.28%
其他
20.31%
股東類型
持股股東
佔比
Corporation
64.86%
Investment Advisor
9.43%
Individual Investor
5.14%
Hedge Fund
5.00%
Insurance Company
4.41%
Research Firm
0.29%
其他
10.86%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
35
533.06K
19.14%
-233.10K
2025Q2
36
2.50M
89.88%
-104.83K
2025Q1
37
2.45M
84.60%
+78.00K
2024Q4
35
23.50M
84.37%
-314.30K
2024Q3
34
23.55M
84.52%
-115.49K
2024Q2
31
25.52M
91.61%
+1.51M
2024Q1
30
23.87M
85.67%
+1.61M
2023Q4
31
22.12M
83.66%
-222.95K
2023Q3
30
22.20M
83.99%
-4.35K
2023Q2
29
22.04M
83.43%
-335.52K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
M.Arkin Dermatology, Ltd.
1.81M
64.86%
--
--
Jun 11, 2025
Arkin (Moshe)
143.26K
5.14%
+105.12K
+275.67%
Jun 11, 2025
Opaleye Management Inc.
139.39K
5%
+139.39K
--
Aug 22, 2025
Migdal Insurance and Financial Holdings Ltd
122.75K
4.41%
--
--
Jun 30, 2025
Raymond James Financial Services Advisors, Inc.
7.81K
0.28%
-871.00
-10.03%
Jun 30, 2025
UBS Financial Services, Inc.
7.34K
0.26%
+3.53K
+92.62%
Jun 30, 2025
Morgan Stanley & Co. LLC
5.33K
0.19%
-3.90K
-42.24%
Jun 30, 2025
Raymond James & Associates, Inc.
2.68K
0.1%
+162.00
+6.44%
Jun 30, 2025
Steward Partners Investment Advisory, LLC
316.00
0.01%
-200.00
-38.76%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
308.00
0.01%
-1.00
-0.32%
Jun 30, 2025
查看更多
持股ETF
更新時間: 11月2日 週日
更新時間: 11月2日 週日
機構名稱
佔比
Invesco Raymond James SB-1 Equity ETF
0%
Invesco Raymond James SB-1 Equity ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
